Dunning BE - Search Results

1

The effect of food on the oral bioavailability and the pharmacodynamic actions of the insulinotropic agent nateglinide in healthy subjects.

Karara AH, Dunning BE, McLeod JF. Karara AH, et al. Among authors: dunning be. J Clin Pharmacol. 1999 Feb;39(2):172-9. doi: 10.1177/00912709922007606. J Clin Pharmacol. 1999. PMID: 11563410 Clinical Trial.

2

Nateglinide (Starlix): update on a new antidiabetic agent.

Phillips LS, Dunning BE. Phillips LS, et al. Among authors: dunning be. Int J Clin Pract. 2003 Jul-Aug;57(6):535-41. Int J Clin Pract. 2003. PMID: 12918894 Review.

3

Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.

Hu S, Wang S, Fanelli B, Bell PA, Dunning BE, Geisse S, Schmitz R, Boettcher BR. Hu S, et al. Among authors: dunning be. J Pharmacol Exp Ther. 2000 May;293(2):444-52. J Pharmacol Exp Ther. 2000. PMID: 10773014

4

Tissue selectivity of antidiabetic agent nateglinide: study on cardiovascular and beta-cell K(ATP) channels.

Hu S, Wang S, Dunning BE. Hu S, et al. Among authors: dunning be. J Pharmacol Exp Ther. 1999 Dec;291(3):1372-9. J Pharmacol Exp Ther. 1999. PMID: 10565863

5

Pharmacodynamics of vildagliptin in patients with type 2 diabetes during OGTT.

He YL, Wang Y, Bullock JM, Deacon CF, Holst JJ, Dunning BE, Ligueros-Saylan M, Foley JE. He YL, et al. Among authors: dunning be. J Clin Pharmacol. 2007 May;47(5):633-41. doi: 10.1177/0091270006299137. J Clin Pharmacol. 2007. PMID: 17442688 Clinical Trial.

6

Rapid acting insulinotropic agents: restoration of early insulin secretion as a physiologic approach to improve glucose control.

Pratley RE, Foley JE, Dunning BE. Pratley RE, et al. Among authors: dunning be. Curr Pharm Des. 2001 Sep;7(14):1375-97. doi: 10.2174/1381612013397348. Curr Pharm Des. 2001. PMID: 11472274 Review.

7

Glucose-dependent and glucose-sensitizing insulinotropic effect of nateglinide: comparison to sulfonylureas and repaglinide.

Hu S, Wang S, Dunning BE. Hu S, et al. Among authors: dunning be. Int J Exp Diabetes Res. 2001;2(1):63-72. doi: 10.1155/edr.2001.63. Int J Exp Diabetes Res. 2001. PMID: 12369728 Free PMC article.

8

The mechanisms underlying the unique pharmacodynamics of nateglinide.

Hu S, Boettcher BR, Dunning BE. Hu S, et al. Among authors: dunning be. Diabetologia. 2003 Mar;46 Suppl 1:M37-43. doi: 10.1007/s00125-002-0935-1. Epub 2002 Nov 8. Diabetologia. 2003. PMID: 12652357 Review.

9

Differential effects of short and long duration insulinotropic agents on meal-related glucose excursions.

de Souza CJ, Russo P, Lozito R, Dunning BE. de Souza CJ, et al. Among authors: dunning be. Diabetes Obes Metab. 2001 Apr;3(2):73-83. doi: 10.1046/j.1463-1326.2001.00114.x. Diabetes Obes Metab. 2001. PMID: 11298729

10

Pharmacologic restoration of the early insulin response in pre-diabetic monkeys controls mealtime glucose excursions without peripheral hyperinsulinaemia.

Dunning BE, Deacon R, Gutierrez C, Paladini S, Valentin MA, Foley JE. Dunning BE, et al. Diabetologia. 2003 Mar;46 Suppl 1:M22-9. doi: 10.1007/s00125-002-0933-3. Epub 2002 Nov 9. Diabetologia. 2003. PMID: 12652355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters